Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1441 AL 1455

mTOR Pathway - Novel Modulator of Astrocyte Activity

Latacz A, Russell JA, Ocłon E, Zubel-łojek J, Pierzchała-Koziec K.

Folia Biol (Krakow). 2015;63(2):95-105. doi: 10.3409/fb63_2.95.

What Engineering Technology Could Do for Quality of Life in Parkinson's Disease: A Review of Current Needs and Opportunities

Stamford JA, Schmidt PN, Friedl KE.

IEEE J Biomed Health Inform. 2015 Nov;19(6):1862-72. doi: 10.1109/JBHI.2015.2464354. Epub 2015 Aug 4.

Neuroinflammatory processes in cognitive disorders: Is there a role for flavonoids and n-3 polyunsaturated fatty acids in counteracting their detrimental effects?

Vauzour D, Martinsen A, Layé S.

Neurochem Int. 2015 Oct;89:63-74. doi: 10.1016/j.neuint.2015.08.004. Epub 2015 Aug 7.

Left ventricular free wall perforation and left atrial dissection: unusual complication of radiofrequency catheter ablation for Wolf-Parkinson-White syndrome

Hirata K, Takahashi T, Yasumoto H, Shinzato T.

BMJ Case Rep. 2015 Aug 10;2015:bcr2015211221. doi: 10.1136/bcr-2015-211221.

Results of the early stage PD MED study: revelation or recapitulation?

Worth P.

Pract Neurol. 2015 Dec;15(6):408-10. doi: 10.1136/practneurol-2015-001149. Epub 2015 Aug 10.

p38 MAPK and PI3K/AKT Signalling Cascades inParkinson's Disease

Jha SK, Jha NK, Kar R, Ambasta RK, Kumar P.

Int J Mol Cell Med. 2015 Spring;4(2):67-86.

Enhancing both motor and cognitive functioning in Parkinson's disease: Aerobic exercise as a rehabilitative intervention

Duchesne C, Lungu O, Nadeau A, Robillard ME, Boré A, Bobeuf F, Lafontaine AL, Gheysen F, Bherer L, Doyon J.

Brain Cogn. 2015 Oct;99:68-77. doi: 10.1016/j.bandc.2015.07.005. Epub 2015 Aug 7.

Quantitative assessment of non-motor fluctuations in Parkinson's disease using the Non-Motor Symptoms Scale (NMSS)

Storch A, Schneider CB, Klingelhöfer L, Odin P, Fuchs G, Jost WH, Martinez-Martin P, Koch R, Reichmann H, Chaudhuri KR; NoMoFlu-PD study group; Ebersbach G.

J Neural Transm (Vienna). 2015 Dec;122(12):1673-84. doi: 10.1007/s00702-015-1437-x. Epub 2015 Aug 12.

A Kinect-Based System for Lower Limb Rehabilitation in Parkinson's Disease Patients: a Pilot Study

Palacios-Navarro G, García-Magariño I, Ramos-Lorente P.

J Med Syst. 2015 Sep;39(9):103. doi: 10.1007/s10916-015-0289-0. Epub 2015 Aug 12.

Dietary intake of iron, zinc, copper, and risk of Parkinson's disease: a meta-analysis

Cheng P, Yu J, Huang W, Bai S, Zhu X, Qi Z, Shao W, Xie P.

Neurol Sci. 2015 Dec;36(12):2269-75. doi: 10.1007/s10072-015-2349-0. Epub 2015 Aug 12.

The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina

Cascio C, Deidda I, Russo D, Guarneri P.

Steroids. 2015 Nov;103:31-41. doi: 10.1016/j.steroids.2015.08.002. Epub 2015 Aug 8.

Evaluation and Management of Neurogenic Bladder: What Is New in China?

Liao L.

Int J Mol Sci. 2015 Aug 10;16(8):18580-600. doi: 10.3390/ijms160818580.

Safinamide: Benefit Assessment According to §35a Social Code Book V

Institute for Quality and Efficiency in Health Care.

Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Aug 13. Extract of Dossier Assessment No. A15-18.

Expanding the ubiquitin code through post-translational modification

Herhaus L, Dikic I.

EMBO Rep. 2015 Sep;16(9):1071-83. doi: 10.15252/embr.201540891. Epub 2015 Aug 12.

Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits

Dutta D, Mohanakumar KP.

Neurochem Int. 2015 Oct;89:181-90. doi: 10.1016/j.neuint.2015.08.005. Epub 2015 Aug 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias